Instructions for use Menovazin solution alcohol bottle 100 ml
Composition
active ingredients: menthol, novocaine (procaine hydrochloride), anestezin (benzocaine);
100 ml of solution contain menthol – 2.5 g, novocaine (procaine hydrochloride) – 1 g, anestezin (benzocaine) – 1 g;
excipient: ethanol 70%.
Dosage form
Solution for external use, alcohol.
Main physicochemical properties: colorless, transparent liquid with a menthol odor.
Pharmacotherapeutic group
Topical agents for joint and muscle pain.
ATX code M02A X.
Pharmacological properties
Pharmacodynamics
The drug has an antipruritic and local anesthetic effect. When applied to the skin and mucous membranes, it causes irritation of nerve endings, which is accompanied by a feeling of cold, slight burning and tingling.
Has a mild analgesic effect.
Pharmacokinetics
When applied topically, the drug does not enter the bloodstream.
Indication
The drug is prescribed for neuralgia, myalgia, and arthralgia.
Contraindication
The drug is contraindicated in case of hypersensitivity to novocaine and other components of the drug.
Special safety measures.
Do not apply to damaged skin or skin with allergic manifestations. Do not apply to facial skin.
You should not violate the rules for using the medicine, this may harm your health.
Interaction with other medicinal products and other types of interactions
The components of the drug (novocaine, anestezin) weaken the antibacterial effect of sulfonamide drugs. Enhance the effects of drugs with local anesthetic action.
If you are taking any other medications at the same time, you should inform your doctor.
Use during pregnancy or breastfeeding
During pregnancy and breastfeeding, the use of the drug is possible only when the expected benefit to the mother outweighs the potential risk to the fetus or child.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Method of administration and doses
The drug is used externally. Painful areas of the skin are rubbed with Menovazin 2-3 times a day. The course of treatment depends on the form, severity of the disease, the effect of the drug, as well as the nature of the treatment (monotherapy or in combination with other drugs).
Children.
Do not use in children under 12 years of age.
Overdose
With prolonged use, dizziness, general weakness, decreased blood pressure, allergic reactions are possible. If such symptoms appear, the drug should be discontinued, the remains should be washed off the skin surface with water, and symptomatic therapy should be carried out.
Adverse reactions
Allergic reactions are possible (hyperemia, skin irritation, itching, rash, edema, urticaria).
If any adverse reactions occur, you should consult a doctor!
Expiration date
2 years.
The drug cannot be used after the expiration date indicated on the package.
Storage conditions
Store in original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Packaging
40 ml or 100 ml in bottles; 1 bottle in a pack or without a pack. 50 ml in bottles sealed with a mechanical sprayer; 1 bottle in a pack.
Vacation category
Without a prescription.
Producer
PrJSC Pharmaceutical Factory "Viola".
Location of the manufacturer and its business address
69063, Ukraine, Zaporizhia, Akademika Amosova St., 75.
Applicant
PrJSC Pharmaceutical Factory "Viola".
Applicant's location
69063, Ukraine, Zaporizhia, Akademika Amosova St., 75.
